Literature DB >> 25212238

Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.

Aziliz Hervault1, Nguyen Th Kim Thanh.   

Abstract

Magnetic nanoparticles have been widely investigated for their great potential as mediators of heat for localised hyperthermia therapy. Nanocarriers have also attracted increasing attention due to the possibility of delivering drugs at specific locations, therefore limiting systematic effects. The enhancement of the anti-cancer effect of chemotherapy with application of concurrent hyperthermia was noticed more than thirty years ago. However, combining magnetic nanoparticles with molecules of drugs in the same nanoformulation has only recently emerged as a promising tool for the application of hyperthermia with combined chemotherapy in the treatment of cancer. The main feature of this review is to present the recent advances in the development of multifunctional therapeutic nanosystems incorporating both magnetic nanoparticles and drugs, and their superior efficacy in treating cancer compared to either hyperthermia or chemotherapy as standalone therapies. The principle of magnetic fluid hyperthermia is also presented.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25212238     DOI: 10.1039/c4nr03482a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  67 in total

1.  Diagnostic and Therapeutic Nanomedicine.

Authors:  Jinmyoung Joo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Assessing the hyperthermic properties of magnetic heterostructures: the case of gold-iron oxide composites.

Authors:  Elvira Fantechi; Paula M Castillo; Erika Conca; Francesca Cugia; Claudio Sangregorio; Maria Francesca Casula
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

3.  Magnetic calcium phosphates nanocomposites for the intracellular hyperthermia of cancers of bone and brain.

Authors:  Alessio Adamiano; Victoria M Wu; Francesca Carella; Gianrico Lamura; Fabio Canepa; Anna Tampieri; Michele Iafisco; Vuk Uskoković
Journal:  Nanomedicine (Lond)       Date:  2019-05       Impact factor: 5.307

Review 4.  Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.

Authors:  Behdokht Bahrami; Mousa Mohammadnia-Afrouzi; Peyman Bakhshaei; Yaghoub Yazdani; Ghasem Ghalamfarsa; Mehdi Yousefi; Sanam Sadreddini; Farhad Jadidi-Niaragh; Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-07-05

Review 5.  Magnetic nanoparticles and nanocomposites for remote controlled therapies.

Authors:  Anastasia K Hauser; Robert J Wydra; Nathanael A Stocke; Kimberly W Anderson; J Zach Hilt
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

6.  MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.

Authors:  Reju George Thomas; Myeong Ju Moon; Suchithra Poilil Surendran; Hyeong Ju Park; In-Kyu Park; Byeong-Il Lee; Yong Yeon Jeong
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

7.  Open multi-culture platform for simple and flexible study of multi-cell type interactions.

Authors:  Yasmín R Álvarez-García; Karla P Ramos-Cruz; Reinaldo J Agostini-Infanzón; Loren E Stallcop; David J Beebe; Jay W Warrick; Maribella Domenech
Journal:  Lab Chip       Date:  2018-10-09       Impact factor: 6.799

Review 8.  Electrospun Nanofibers for Cancer Therapy.

Authors:  Huanhuan Luo; Tianyang Jie; Li Zheng; Chenglong Huang; Gang Chen; Wenguo Cui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Folate encapsulation in PEG-diamine grafted mesoporous Fe3O4 nanoparticles for hyperthermia and in vitro assessment.

Authors:  Ahmaduddin Khan; Niroj Kumar Sahu
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

10.  High Temperature Drives Topoisomerase Mediated Chromosomal Break Repair Pathway Choice.

Authors:  Mohamed E Ashour; Walaa Allam; Waheba Elsayed; Reham Atteya; Menattallah Elserafy; Sameh Magdeldin; Mohamed K Hassan; Sherif F El-Khamisy
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.